Ondansetron Stada

Ondondansetron, the active ingredient in Ondansetron Stada, is a 5-HT3 receptor antagonist presented as an intravenous solution for injection use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult and pediatric patients.

GNH USA supplies Ondansetron Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Ondansetron Stada acts  ​       ​  ​  ​  ​  ​  ​  ​   ​